Moxifloxacin Oral, Injection Products
Recognized Interpretive Criteria
Additional FDA-identified interpretive criteria
|
Minimum Inhibitory |
Disk Diffusion |
||||
---|---|---|---|---|---|---|
Pathogen |
S |
I |
R |
S |
I |
R |
Enterobacterales |
≤2 |
4 |
≥8 |
≥19 |
16–18 |
≤15 |
Enterococcus faecalis |
≤1 |
2 |
≥4 |
≥18 |
15–17 |
≤14 |
Staphylococcus spp. |
M100 standard is recognized |
|||||
Haemophilus influenzae and |
M100 standard is recognized |
|||||
Streptococcus pneumoniae |
M100 standard is recognized |
|||||
Anaerobes |
M100 standard is recognized |
|||||
Yersinia pestis |
≤0.25 |
- |
- |
- |
- |
- |
S = Susceptible; I = Intermediate; R = Resistant